AARD

Aardvark Therapeutics (AARD)

About Aardvark Therapeutics (AARD)

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Details

Daily high
$4.10
Daily low
$3.55
Price at open
--
52 Week High
$17.94
52 Week Low
$3.55
Market cap
82.1M
Dividend yield
0.00%
Volume
30
Avg. volume
545,997
P/E ratio
-1.42

Aardvark Therapeutics News

Details

Daily high
$4.10
Daily low
$3.55
Price at open
--
52 Week High
$17.94
52 Week Low
$3.55
Market cap
82.1M
Dividend yield
0.00%
Volume
30
Avg. volume
545,997
P/E ratio
-1.42